Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,515 | -47,743 | -36,778 | -22,609 | -10,588 |
| Depreciation Amortization | 365 | 1,273 | 935 | 620 | 304 |
| Accounts receivable | 316 | -317 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 220 | -404 | 1,426 | -1,423 | -914 |
| Other Working Capital | -2,561 | 1,690 | 1,396 | -1,593 | -996 |
| Other Operating Activity | 355 | 4,965 | 2,081 | 3,236 | 1,576 |
| Operating Cash Flow | $-12,820 | $-40,536 | $-30,940 | $-21,769 | $-10,618 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,499 | -25,020 | N/A | N/A | N/A |
| PPE Investments | -396 | -2,322 | -2,008 | -1,827 | -1,525 |
| Investing Cash Flow | $2,103 | $-27,342 | $-2,008 | $-1,827 | $-1,525 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -41 | -135 | -95 | -55 | -17 |
| Common Stock Issued | 169 | 50,879 | 50,815 | 357 | N/A |
| Other Financing Activity | 0 | 39,813 | 39,813 | 37,501 | 38,384 |
| Financing Cash Flow | $128 | $90,557 | $90,533 | $37,803 | $38,367 |
| Beginning Cash Position | 59,071 | 36,392 | 35,909 | 35,909 | 35,909 |
| End Cash Position | 48,482 | 59,071 | 93,494 | 50,116 | 62,133 |
| Net Cash Flow | $-10,589 | $22,679 | $57,585 | $14,207 | $26,224 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,820 | -40,536 | -30,940 | -21,769 | -10,618 |
| Capital Expenditure | -396 | -2,322 | -2,008 | -1,827 | -1,525 |
| Free Cash Flow | -13,216 | -42,858 | -32,948 | -23,596 | -12,143 |